Zhenzhen Mu

Shenyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Inhibiting melanoma tumor growth: the role of oxidative stress-associated LINC02132 and COPDA1 long non-coding RNAs.

Inhibiting melanoma tumor growth: the role of oxidative stress-associated LINC02132 and COPDA1 long non-coding RNAs.

Journal: Frontiers in immunology

Published: January 10, 2025

JAK inhibitors in immune regulation and treatment of vitiligo.

JAK inhibitors in immune regulation and treatment of vitiligo.

Journal: Cytokine & growth factor reviews

Published: September 20, 2024

Arctiin Alleviates Atopic Dermatitis Against Inflammation and Pyroptosis Through Suppressing TLR4/MyD88/NF-κB and NLRP3/Caspase-1/GSDMD Signaling Pathways.

Arctiin Alleviates Atopic Dermatitis Against Inflammation and Pyroptosis Through Suppressing TLR4/MyD88/NF-κB and NLRP3/Caspase-1/GSDMD Signaling Pathways.

Journal: Journal of inflammation research

Published: June 29, 2024

Recent advances in shikonin for the treatment of immune-related diseases: Anti-inflammatory and immunomodulatory mechanisms.

Recent advances in shikonin for the treatment of immune-related diseases: Anti-inflammatory and immunomodulatory mechanisms.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 27, 2023

Prevalence of cutaneous manifestations in COVID-19: A meta-analysis.

Prevalence of cutaneous manifestations in COVID-19: A meta-analysis.

Journal: The Journal of dermatology

Published: September 13, 2022

The differential impact of air pollutants on acute urticaria and chronic urticaria: a time series analysis.

The differential impact of air pollutants on acute urticaria and chronic urticaria: a time series analysis.

Journal: Environmental science and pollution research international

Published: March 09, 2022

Therapeutic Effects of Shikonin on Skin Diseases: A Review.

Therapeutic Effects of Shikonin on Skin Diseases: A Review.

Journal: The American journal of Chinese medicine

Published: December 28, 2021

Mapping knowledge structures and theme trends of atopic dermatitis: a co-word biclustering and quantitative analysis of the publication between 2015 and 2019.

Mapping knowledge structures and theme trends of atopic dermatitis: a co-word biclustering and quantitative analysis of the publication between 2015 and 2019.

Journal: The Journal of dermatological treatment

Published: March 25, 2021

Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis.

Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis.

Journal: Dermatology (Basel, Switzerland)

Published: February 19, 2021

Mdivi-1 alleviates atopic dermatitis through the inhibition of NLRP3 inflammasome.

Mdivi-1 alleviates atopic dermatitis through the inhibition of NLRP3 inflammasome.

Journal: Experimental dermatology

Published: November 11, 2020

Sulforaphane has a therapeutic effect in an atopic dermatitis murine model and activates the Nrf2/HO‑1 axis.

Sulforaphane has a therapeutic effect in an atopic dermatitis murine model and activates the Nrf2/HO‑1 axis.

Journal: Molecular medicine reports

Published: October 25, 2018

Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene.

Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene.

Journal: Inflammation

Published: September 28, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026